Ongoing Glucose Monitoring in Individuals With and Without Diabetes
-
By
-
Minna Johansson
-
Justin A. Dower
-
Kasia J. Lipska
-
September 1, 2026
Clinical Scorecard: Ongoing Glucose Monitoring in Individuals With and Without Diabetes
At a Glance
| Category | Detail |
|---|
| Condition | Continuous Glucose Monitoring (CGM) |
| Key Mechanisms | Measures blood glucose continuously, alerts users to high or low levels. |
| Target Population | Individuals with type 1 diabetes, type 2 diabetes, and individuals without diabetes. |
| Care Setting | Outpatient settings for diabetes management. |
Key Highlights
- CGMs provide detailed records of blood glucose concentrations and changes over time.
- Use of CGMs is increasing among individuals without diabetes, despite lack of evidence for health improvement.
- CGMs may assist in insulin dosage adjustments for individuals with type 2 diabetes.
- Potential drawbacks include sleep interruption and stress from notifications.
- CGMs may simplify management for those requiring frequent blood glucose measurements.
Guideline-Based Recommendations
Diagnosis
Management
- CGMs may assist in modifying insulin dosage or timing for individuals with type 2 diabetes.
Monitoring & Follow-up
- Continuous glucose data may reduce reliance on finger-stick testing.
Risks
- CGMs may irritate the skin, malfunction, or detach.
Patient & Prescribing Data
Individuals with type 1 diabetes, type 2 diabetes, and those without diabetes.
CGMs may provide benefit for individuals with type 2 diabetes on insulin, but most are advised to focus on healthy lifestyle strategies.
Clinical Best Practices
- Discuss concerns about diabetes prevention or care with a clinician.
- Consider CGM use for individuals needing to measure blood glucose several times daily.
Related Resources & Content
